HEPATIC CLEARANCE OF DRUGS .3. ADDITIONAL EXPERIMENTAL-EVIDENCE SUPPORTING WELL-STIRRED MODEL, USING METABOLITE (MEGX) GENERATED FROM LIDOCAINE UNDER VARYING HEPATIC BLOOD-FLOW RATES AND LINEAR CONDITIONS IN PERFUSED RAT-LIVER INSITU PREPARATION

被引：81

作者：

PANG, SK

ROWLAND, M

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143

[2] UNIV CALIF SAN FRANCISCO,DIV GRAD,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1977年 / 5卷 / 06期

关键词：

D O I：

10.1007/BF01059690

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：681 / 699

页数：19